COVID-19: патогенез
via Viking700: Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients и Uni Innsbruck: Schwere Verläufe bei hohen Antikörpertitern, leichte bei guter T-Zell-Aktivität
Die Studie der Medizinischen Universität Innsbruck an Geweben von COVID-19 Patienten liefert überraschende Einsichten in den Verlauf von Corona-Infektionen. Die Daten belegen, dass hohe SARS-CoV-2-Antikörpertiter mit einem schweren Krankheitsverlauf verbunden sind. Eine robuste T-Zell-Aktivität hingegen korreliert signifikant mit leichten Symptomen. Die Ergebnisse sind auch für andere respiratorische Erkrankungen relevant.
T cells play a fundamental role in the early control and clearance of
many viral infections of the respiratory system. In SARS-CoV-2-infected
individuals, lymphopenia with drastically reduced CD4+ and CD8+
T cells correlates with Coronavirus disease 2019 (COVID-19)-associated
disease severity and mortality. In this study, we characterized cellular
and humoral immune responses induced in patients with mild, severe and
critical COVID-19. Peripheral blood mononuclear cells of 37 patients
with mild, severe and critical COVID-19 and 10 healthy individuals were
analyzed by IFNγ ELISpot and multi-color flow cytometry upon stimulation
with peptide pools covering complete immunodominant SARS-CoV-2 matrix,
nucleocapsid and spike proteins. In addition SARS-CoV-2 antibody levels,
neutralization abilities and anaphylatoxin levels were evaluated by
various commercially available ELISA platforms. Our data clearly
demonstrates a significantly stronger induction of SARS-CoV-2 specific
CD8+ T lymphocytes and higher IFNγ production in patients
with mild compared to patients with severe or critical COVID-19. In all
patients SARS-CoV-2-specific antibodies with similar neutralizing
activity were detected, but highest titers of total IgGs were observed
in critical patients. Finally, elevated anaphylatoxin C3a and C5a levels
were identified in severe and critical COVID-19 patients probably
caused by aberrant immune complex formation due to elevated antibody
titers in these patients. Crucially, we provide a full picture of
cellular and humoral immune responses of COVID-19 patients and prove
that robust polyfunctional CD8+ T cell responses concomitant
with low anaphylatoxin levels correlate with mild infections. In
addition, our data indicates that high SARS-CoV-2 antibody titers are
associated with severe disease progression.